Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine use beyond 24 horse Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KASCH-NGHA

drug protocol number
RC20/160/R
drug sponsor
KAIMRC
drug study
Dexmedetomidine
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase